News & Events
-
July 20, 2023
TTC Announces Publication in Transplantation
C-Path’s Transplant Therapeutics Consortium is pleased to announce the recent publication in Transplantation by William Fitzsimmons and Maarten Naesens, “Acute Rejection After Kidney Transplant—An Endpoint Not Predictive of Treatment Effect on Graft Survival.” The article highlights the lack of consistent treatment effect of BPAR on graft survival and the work we are doing in TTC to improve upon the current... -
July 18, 2023
C-Path Integrates European Offices to Optimize Global Operations and Collaborative Partnerships
C-Path ts activity in Europe and broaden its global operations. C-Path operates in Europe as a nonprofit organisation that builds consensus among its stakeholders from around the world to improve public health. The organisation shares expertise, data, risks and costs to move regulatory science forward.
-
May 31, 2023
C-Path’s Transplant Therapeutics Consortium’s Work Highlighted in Recent Publication in the American Journal of Transplantation
C-Path’s Transplant Therapeutics Consortium is pleased to announce the recent publication in the American Journal of Transplantation by Klemens Budde and Bruce Kaplan, “Stronger together: lessons from the iBox qualification process.” The article highlights TTC’s work as the only community-based public-private partnership focused on reinvigorating drug development in transplantation. As the manuscript states, “The close collaboration... -
April 25, 2023
C-Path Europe: A Global Vision of Success
TUCSON, Ariz. and AMSTERDAM, April 26, 2023 — As an organization that generates regulatory-endorsed solutions and methodologies to accelerate drug development, Critical Path Institute (C-Path) today shared a year-in-review of its European-focused activities to advance global regulatory science. “We are pleased with the progress and continued development of our global efforts in the regulatory and... -
December 20, 2022
C-Path’s Transplant Therapeutics Consortium Receives EMA Qualification Opinion for iBox Scoring System
The iBox Scoring System is available for use in kidney transplant clinical trials as a novel secondary endpoint prognostic for allograft loss.